Malaria is one of the most deadly diseases in world affecting more than 500 million people with over 2 million deaths per year. Four species of Plasmodium cause human disease: Plasmodium vivax (P. vivax), Plasmodium malarie (P. malarie), Plasmodium ovale (P. ovale) and Plasmodium falciparum (P. falciparum). For the treatment of malaria there is a great number of drugs available, but limiting factors are: high prices, toxicity and increased resistance of parasite. For these reasons there is great need for development of new drugs, increasing control of existing and finding new admission in treatment of malaria.
TY - JOUR
AU - Opsenica, Dejan
AU - Opsenica, Igor
PY - 2006
UR - http://cer.ihtm.bg.ac.rs/handle/123456789/273
AB - Malaria is one of the most deadly diseases in world affecting more than 500 million people with over 2 million deaths per year. Four species of Plasmodium cause human disease: Plasmodium vivax (P. vivax), Plasmodium malarie (P. malarie), Plasmodium ovale (P. ovale) and Plasmodium falciparum (P. falciparum). For the treatment of malaria there is a great number of drugs available, but limiting factors are: high prices, toxicity and increased resistance of parasite. For these reasons there is great need for development of new drugs, increasing control of existing and finding new admission in treatment of malaria.
PB - Srpsko hemijsko društvo, Beograd
T2 - Hemijski pregled
T1 - Malaria ancient disease: New challenges
T1 - Malarija stara bolest - novi izazovi
VL - 47
IS - 5
SP - 108
EP - 113
ER -
@article{
author = "Opsenica, Dejan and Opsenica, Igor",
year = "2006",
url = "http://cer.ihtm.bg.ac.rs/handle/123456789/273",
abstract = "Malaria is one of the most deadly diseases in world affecting more than 500 million people with over 2 million deaths per year. Four species of Plasmodium cause human disease: Plasmodium vivax (P. vivax), Plasmodium malarie (P. malarie), Plasmodium ovale (P. ovale) and Plasmodium falciparum (P. falciparum). For the treatment of malaria there is a great number of drugs available, but limiting factors are: high prices, toxicity and increased resistance of parasite. For these reasons there is great need for development of new drugs, increasing control of existing and finding new admission in treatment of malaria.",
publisher = "Srpsko hemijsko društvo, Beograd",
journal = "Hemijski pregled",
title = "Malaria ancient disease: New challenges, Malarija stara bolest - novi izazovi",
volume = "47",
number = "5",
pages = "108-113"
}
Opsenica D, Opsenica I. Malarija stara bolest - novi izazovi. Hemijski pregled. 2006;47(5):108-113
Opsenica, D.,& Opsenica, I. (2006). Malarija stara bolest - novi izazovi.
Hemijski pregledSrpsko hemijsko društvo, Beograd., 47(5), 108-113.
Opsenica Dejan, Opsenica Igor, "Malarija stara bolest - novi izazovi" 47, no. 5 (2006):108-113
